Management and complications of tubo-ovarian abscesses: a brief literature review
1. Matsubara S, Mabuchi S, Takeda Y, Kawahara N, Kobayashi H. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer. PLoS One. 2021;16(5):e0247635. doi: 10.1371/journal.pone.0248871.
2. Nie D, Gong H, Mao X, Li Z. Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study. Gynecol Oncol. 2019;152(2):259-564. doi: 10.1016/j.ygyno.2018.11.034.
3. Jing X, Li C, Sun J, et al. Systemic Inflammatory Response Markers Associated with Infertility and Endometrioma or Uterine Leiomyoma in Endometriosis. Ther Clin Risk Manag. 2020;16:403-412. doi: 10.2147/TCRM.S232849.
4. Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol. 1991;164(6 Pt 1):1556-61; discussion 1561-2. doi: 10.1016/0002-9378(91)91436-z.
5. Fouks Y, Cohen A, Levin I, Grisaru D, Almog B, Lessing JB. Surgical intervention in patients with tubo-ovarian abscess: clinical predictors and a simple risk score. J Minim Invasive Gynecol. 2019;26(3):535-543. doi: 10.1016/j.jmig.2018.06.013.
6. Erenel H, Aydogan Mathyk B, Sal V, Ayhan I, Karatas S, Koc B. Usefulness of serum procalcitonin levels in predicting tubo-ovarian abscess in patients with acute pelvic inflammatory disease. Gynecol Obstet Invest. 2017;82(3):262-266. doi: 10.1159/000449161.
7. Lee SW, Kim YJ, Chung HH, Song YS, Seo JS. Predictive markers of tubo-ovarian abscess in pelvic inflammatory disease. Gynecol Obstet Invest. 2016;81(1):97-104. doi: 10.1159/000381772.
8. Miettinen AK, Heinonen PK, Laippala P, Paavonen J. Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol. 1993;169(4):1143-1149. doi: 10.1016/0002-9378(93)90271-J.
9. Jennings LK, Krywko DM. Pelvic Inflammatory Disease. 2023 Mar 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
10. Kreisel K, Torrone E, Bernstein K, Hong J, Gorwitz R. Prevalence of Pelvic Inflammatory Disease in Sexually Experienced Women of Reproductive Age - United States, 2013-2014. MMWR Morb Mortal Wkly Rep. 2017;66(3):80-83. doi: 10.15585/mmwr.mm6603a3.
11. Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.
12. Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol. 1993;36(2):433-444. doi: 10.1097/00003081-199306000-00028.
13. Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med. 2015;372(21):2039-2048. doi: 10.1056/NEJMra1411426.
14. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet. 2000;356(9234):1013-1019. doi: 10.1016/S0140-6736(00)02699-4.
15. Lee YC, Min D, Holcomb K, Buhl A, DiMaio TM, Abulafia O. Computed tomography guided core needle biopsy diagnosis of pelvic actinomycosis. Gynecol Oncol. 2000;79(3):318-323. doi: 10.1006/gyno.2000.5994.
16. Hillier SL, Bernstein KT, Aral S. A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease. J Infect Dis. 2021;224(12 Suppl 2):S23-S28. doi: 10.1093/infdis/jiab116.
17. Jackson SL, Soper DE. Pelvic inflammatory disease in the postmenopausal woman. Infect Dis Obstet Gynecol. 1999;7(5):248-52. doi: 10.1002/(SICI)1098-0997(1999)7:5<248::AID-IDOG8>3.0.CO;2-V.
18. Reekie J, Donovan B, Guy R, et al; Chlamydia and Reproductive Health Outcome Investigators; Chlamydia and Reproductive Health Outcome Investigators. Risk of Pelvic Inflammatory Disease in Relation to Chlamydia and Gonorrhea Testing, Repeat Testing, and Positivity: A Population-Based Cohort Study. Clin Infect Dis. 2018;66(3):437-443. doi: 10.1093/cid/cix769.
19. De Muylder X, Laga M, Tennstedt C, Van Dyck E, Aelbers GN, Piot P. The role of Neisseria gonorrhoeae and Chlamydia trachomatis in pelvic inflammatory disease and its sequelae in Zimbabwe. J Infect Dis. 1990;162(2):501-5. doi: 10.1093/infdis/162.2.501.
20. Cox SM, Shelburne P, Mason RA, Gloyd V, Rodgers M. Role of Neisseria gonorrhoeae and Chlamydia trachomatis in intraabdominal abscess formation in the rat. J Reprod Med. 1991;36(3):202-205.
21. Hsu CT, Roan CH, Rai SY, et al. Actinomycosis affecting the fallopian tube and ovary: report of 3 cases, with special reference to 2 cases following IUD application. Asia Oceania J Obstet Gynaecol. 1988;14(3):275-84. doi: 10.1111/j.1447-0756.1988.tb00104.x.
22. Tugrul Ersak D, Ersak B, Kokanalı MK. The effect of intrauterine device presence and other factors in medical treatment success of tuboovarian abscess. J Gynecol Obstet Hum Reprod. 2021;50(5):101983. doi: 10.1016/j.jogoh.2020.101983.
23. Protopapas AG, Diakomanolis ES, Milingos SD, et al. Tubo-ovarian abscesses in postmenopausal women: gynecological malignancy until proven otherwise? Eur J Obstet Gynecol Reprod Biol. 2004;114(2):203-209. doi: 10.1016/j.ejogrb.2003.10.032.
24. Cohen CR, Sinei S, Reilly M, et al. Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. J Infect Dis. 1998;178(5):1352-1358. doi: 10.1086/314465.
25. Kirkcaldy RD, Harvey A, Papp JR, et al. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveill Summ. 2016;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
26. Groseclose SL, Buckeridge DL. Public Health Surveillance Systems: Recent Advances in Their Use and Evaluation. Annu Rev Public Health. 2017;38:57-79. doi: 10.1146/annurev-publhealth-031816-044348.
27. Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol. 2005;193(4):1323-13230. doi: 10.1016/j.ajog.2005.06.019.
28. Goharkhay N, Verma U, Maggiorotto F. Comparison of CT‐ or ultrasound‐guided drainage with concomitant intravenous antibiotics vs. intravenous antibiotics alone in the management of tubo‐ovarian abscesses. Ultrasound Obstet Gynecol. 2007;29(1):65-69. doi: 10.1002/uog.3890.
29. Kapustian V, Holub Z, Jabor A. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study. Arch Gynecol Obstet. 2018;297(5):1201-1204. doi: 10.1007/s00404-018-4690-z.
30. Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-6222. doi: 10.1158/1078-0432.CCR-14-0442.
31. Vural T, Bayraktar B, Yıldırım Karaca S, Gurbuz E, Ozeren M, Taner CE. Can the risk factors predicting surgical treatment be determined in patients with tubo-ovarian abscess? Gynecol Obstet Reprod Med. 2022;29(1):63-71. doi: 10.21613/GORM.2022.1325.
32. Kim HY, Yang JI, Moon CS. Comparison of severe pelvic inflammatory disease, pyosalpinx, and tubo-ovarian abscess. J Obstet Gynaecol Res. 2015;41(5):742-746. doi: 10.1111/jog.12617.
33. Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol. 2009;23(5):667-678. doi: 10.1016/j.bpobgyn.2009.01.010.
34. Gözüküçük M, Yıldız EG. Is it possible to estimate the need for surgical management in patients with a tubo-ovarian abscess at admission? A retrospective long-term analysis. Gynecol Surg. 2021;18:14. doi: 10.1186/s10397-021-01095-6.
35. Çoşkun B, Şimşir C. Evaluation of risk factors predicting surgical treatment in tuboovarian abscess cases: Tuboavarian Abscess Treatment. Med Sci Discov. 2019;6(10):235-240. doi: 10.36472/msd.v6i10.309.
36. Kose C, Korpe B, Korkmaz V, Ustun YE. The role of systemic immune inflammation index in predicting treatment success in tuboovarian abscesses. Arch Gynecol Obstet. 2023;308(4):1313-1319. doi: 10.1007/s00404-023-07107-4.
37. Mitchell C, Prabhu M. Pelvic inflammatory disease: Current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am. 2013;27(4):793-809. doi: 10.1016/j.idc.2013.08.004.
38. Romosan G, Valentin L. The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory disease: a review of the literature. Arch Gynecol Obstet. 2014;289(4):705-714. doi: 10.1007/s00404-013-3091-6.
39. Spain J, Rheinboldt M. MDCT of pelvic inflammatory disease: a review of the pathophysiology, gamut of imaging findings, and treatment. Emerg Radiol. 2017;24(1):87-93. doi: 10.1007/s10140-016-1444-8.
40. Czeyda-Pommersheim F, Kalb B, Costello J, et al. MRI in pelvic inflammatory disease: a pictorial review. Abdom Radiol (NY). 2017;42(3):935-950. doi: 10.1007/s00261-016-1004-4.
41. Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29(2):108-114. doi: 10.1177/0956462417744099.
42. Park ST, Kim MJ, Ko YB, Lee EJ, Choi YS. Clinical characteristics of genital chlamydia infection in pelvic inflammatory disease. BMC Womens Health. 2017;17(1):5. doi: 10.1186/s12905-016-0356-9.
43. Avendaño ALEM, Totomoch Arroyo JA, Villarreal Portillo DA, Moreno MM. Diagnosis and Treatment of Fitz-Hugh-Curtis Syndrome: Review of Current Literature. Int J Med Sci Clin Res Stud. 2023;3(5):871-873. doi: /10.47191/ijmscrs/v3-i5-16.
44. Bridwell RE, Koyfman A, Long B. High risk and low prevalence diseases: Tubo-ovarian abscess. Am J Emerg Med. 2022;57:70-75. doi: 10.1016/j.ajem.2022.04.026.
45. McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol. 1998;178(6):1272-1278. doi: 10.1016/s0002-9378(98)70333-3.
46. Haggerty CL, Hillier SL, Bass DC, Ness RB. Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis. 2004;39(7):990-995. doi: 10.1086/423963.
47. Dewitt J, Reining A, Allsworth JE, Peipert JF. Tuboovarian abscesses: is size associated with duration of hospitalization & complications? Obstet Gynecol Int. 2010;2010:847041. doi: 10.1155/2010/847041.
48. Demirtas O, Akman L, Demirtas GS, Hursitoglu BS, Yilmaz H. The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience. Arch Gynecol Obstet. 2013;287(3):519-523. doi: 10.1007/s00404-012-2600-3.
49. Ribak R, Schonman R, Sharvit M, Schreiber H, Raviv O, Klein Z. Can the Need for Invasive Intervention in Tubo-ovarian Abscess Be Predicted? The Implication of C-reactive Protein Measurements. J Minim Invasive Gynecol. 2020;27(2):541-547. doi: 10.1016/j.jmig.2019.04.027. Epub 2019 Aug 31.
50. Sharma R. To Evaluate Role of Transvaginal Sonography over Transabdominal Sonography in Delineating Adnexal Masses. JK Science. 2019;21(1):26-34.
51. Jeong WK, Kim Y, Song SY. Tubo-ovarian abscess: CT and pathological correlation. Clin Imaging. 2007;31(6):414-418. doi: 10.1016/j.clinimag.2007.04.024.
52. Hoffman M, Molpus K, Roberts WS, Lyman GH, Cavanagh D. Tuboovarian abscess in postmenopausal women. J Reprod Med. 1990;35(5):525-528.
53. Inal ZO, Inal HA, Gorkem U. Experience of Tubo-Ovarian Abscess: A Retrospective Clinical Analysis of 318 Patients in a Single Tertiary Center in Middle Turkey. Surg Infect (Larchmt). 2018;19(1):54-60. doi: 10.1089/sur.2017.215.
54. Kanyildiz B. Patients with Pelvic Inflammatory Disease vs. Tuboovarian Abscess: Comparison of Follow-Up and Treatment Processes. Clin Med Rev Case Rep. 2022;9(2):383. doi: 10.23937/2378-3656/1410383.
55. Yongue G, Mollier J, Anin S, et al. Tubo-ovarian abscess: A proposed new scoring system to guide clinical management. Int J Gynaecol Obstet. 2022;157(3):588-597. doi: 10.1002/ijgo.13932.
56. Göksever Çelik H, Çelik E, Yüksel S, Baştu E. Different Surgical Techniques in Tubo-Ovarian Abscess Management. Gynecol Obstet Reprod Med. 2017;23(1):32-36. doi: 10.21613/GORM.2016.639.

Copyright (c) 2024 The European Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Article Information
- Article Type Review
- Submitted February 21, 2026
- Published September 3, 2024
- Issue Vol. 10 No. 5 (2024)
- Section Review